LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Opaleye Management Inc.'s Holding History (CIK: 0001595855)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 1,395,000 Value ($000) $1,925 Avg Close — Range —
Q2 2024
Shares 1,670,000 Value ($000) $2,422 Avg Close — Range —
Q1 2024
Shares 3,355,000 Value ($000) $7,482 Avg Close — Range —